Twist Bioscience (TWST) Change in Cash (2017 - 2026)

Twist Bioscience (TWST) has reported Change in Cash for 10 consecutive years, with -$5.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Cash rose 41.54% year-over-year to -$5.3 million in Q2 2026; TTM through Jun 2026 was -$84.3 million, a 121.18% decrease from a year earlier, with the FY2025 full-year figure at -$43.7 million, up 27.34% from the prior year.
• Change in Cash was -$5.3 million for Q2 2026 at Twist Bioscience, up from -$26.1 million in the prior quarter.
• Over five years, Change in Cash peaked at $216.0 million in Q1 2022 and troughed at -$61.2 million in Q4 2022.
• A 5-year average of -$4.1 million and a median of -$12.0 million in 2024 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash surged 327.39% in 2022 and tumbled 1396.73% in 2024, its largest moves.
• Over 5 years, Change in Cash stood at -$61.2 million in 2022, then soared by 67.03% to -$20.2 million in 2023, then surged by 74.84% to -$5.1 million in 2024, then plunged by 578.89% to -$34.4 million in 2025, then soared by 84.65% to -$5.3 million in 2026.
• The last three Change in Cash figures came in at -$5.3 million (Q2 2026), -$26.1 million (Q1 2026), and -$34.4 million (Q4 2025), per Business Quant data.